Intravenous Ketamine for Late-Life Treatment-Resistant Depression: A Pilot Study of Tolerability, Safety, Clinical Benefits, and Effect on Cognition.
Oughli HA, Gebara MA, Ciarleglio A, Lavretsky H, Brown PJ, Flint AJ, Farber NB, Karp JF, Mulsant BH, Reynolds CF 3rd, Roose SP, Yang L, Butters MA, Lenze EJ.
Oughli HA, et al. Among authors: roose sp.
Am J Geriatr Psychiatry. 2023 Mar;31(3):210-221. doi: 10.1016/j.jagp.2022.11.013. Epub 2022 Dec 5.
Am J Geriatr Psychiatry. 2023.
PMID: 36529623
Free PMC article.
Clinical Trial.